Key result
Between 1997 and 2012, ambulatory hypertension treatment visits peaked at 83.3 million in 2008, with angiotensin receptor blocker use increasing from 3% to 18% of visits.
Population
Ambulatory visits by individuals 18 years or older where hypertension was a reported diagnosis and treated…
Design
Cross-sectional
Authors
Loading...
Rising ARB use in hypertension visits through 2012; extends trend data but leaves open outcome associations and current patterns.
Observational
Between 1997 and 2012, ambulatory treatment of hypertension in the US saw a substantial increase in the use of angiotensin receptor blockers and fixed-dose combinations, while the adoption of direct renin inhibitors remained persistently low.
Zhou et al. (2015) conducted an observational in Hypertension. Antihypertensive therapies was evaluated on Annual hypertension treatment visits and proportion of visits treated with specific antihypertensive classes. Between 1997 and 2012, ambulatory hypertension treatment visits peaked at 83.3 million in 2008, with angiotensin receptor blocker use increasing from 3% to 18% of visits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: